nodes	percent_of_prediction	percent_of_DWPC	metapath
Clofazimine—CYP3A4—Rivastigmine—Alzheimer's disease	0.254	0.432	CbGbCtD
Clofazimine—CYP3A4—Donepezil—Alzheimer's disease	0.203	0.345	CbGbCtD
Clofazimine—CYP3A4—Galantamine—Alzheimer's disease	0.131	0.223	CbGbCtD
Clofazimine—Thromboembolism—Memantine—Alzheimer's disease	0.0148	0.0361	CcSEcCtD
Clofazimine—Suicide—Galantamine—Alzheimer's disease	0.0129	0.0314	CcSEcCtD
Clofazimine—Completed suicide—Galantamine—Alzheimer's disease	0.0114	0.0277	CcSEcCtD
Clofazimine—Epigastric pain—Donepezil—Alzheimer's disease	0.0108	0.0262	CcSEcCtD
Clofazimine—Embolism venous—Memantine—Alzheimer's disease	0.00935	0.0227	CcSEcCtD
Clofazimine—Suicide—Memantine—Alzheimer's disease	0.0091	0.0221	CcSEcCtD
Clofazimine—Completed suicide—Memantine—Alzheimer's disease	0.00802	0.0195	CcSEcCtD
Clofazimine—Visual acuity reduced—Memantine—Alzheimer's disease	0.00793	0.0193	CcSEcCtD
Clofazimine—Neuralgia—Donepezil—Alzheimer's disease	0.00748	0.0182	CcSEcCtD
Clofazimine—Embolism—Memantine—Alzheimer's disease	0.00735	0.0179	CcSEcCtD
Clofazimine—Bone pain—Galantamine—Alzheimer's disease	0.007	0.017	CcSEcCtD
Clofazimine—Neuralgia—Memantine—Alzheimer's disease	0.00679	0.0165	CcSEcCtD
Clofazimine—Intestinal obstruction—Rivastigmine—Alzheimer's disease	0.00677	0.0165	CcSEcCtD
Clofazimine—Neuralgia—Rivastigmine—Alzheimer's disease	0.00664	0.0162	CcSEcCtD
Clofazimine—Cystitis noninfective—Galantamine—Alzheimer's disease	0.00655	0.0159	CcSEcCtD
Clofazimine—Cystitis—Galantamine—Alzheimer's disease	0.00647	0.0157	CcSEcCtD
Clofazimine—Bladder pain—Galantamine—Alzheimer's disease	0.00606	0.0147	CcSEcCtD
Clofazimine—Skin discolouration—Donepezil—Alzheimer's disease	0.00575	0.014	CcSEcCtD
Clofazimine—Skin discolouration—Rivastigmine—Alzheimer's disease	0.00511	0.0124	CcSEcCtD
Clofazimine—Cystitis noninfective—Donepezil—Alzheimer's disease	0.00508	0.0123	CcSEcCtD
Clofazimine—Cystitis—Donepezil—Alzheimer's disease	0.00502	0.0122	CcSEcCtD
Clofazimine—Bone pain—Memantine—Alzheimer's disease	0.00493	0.012	CcSEcCtD
Clofazimine—Bone pain—Rivastigmine—Alzheimer's disease	0.00482	0.0117	CcSEcCtD
Clofazimine—Bladder pain—Donepezil—Alzheimer's disease	0.0047	0.0114	CcSEcCtD
Clofazimine—Cystitis noninfective—Memantine—Alzheimer's disease	0.00461	0.0112	CcSEcCtD
Clofazimine—Cystitis—Memantine—Alzheimer's disease	0.00456	0.0111	CcSEcCtD
Clofazimine—Cystitis noninfective—Rivastigmine—Alzheimer's disease	0.00451	0.011	CcSEcCtD
Clofazimine—Cystitis—Rivastigmine—Alzheimer's disease	0.00446	0.0108	CcSEcCtD
Clofazimine—Abdominal pain upper—Galantamine—Alzheimer's disease	0.00445	0.0108	CcSEcCtD
Clofazimine—Hypokalaemia—Galantamine—Alzheimer's disease	0.00443	0.0108	CcSEcCtD
Clofazimine—Bladder pain—Memantine—Alzheimer's disease	0.00427	0.0104	CcSEcCtD
Clofazimine—Bladder pain—Rivastigmine—Alzheimer's disease	0.00417	0.0101	CcSEcCtD
Clofazimine—Lymphadenopathy—Rivastigmine—Alzheimer's disease	0.00393	0.00955	CcSEcCtD
Clofazimine—Weight decreased—Galantamine—Alzheimer's disease	0.00381	0.00926	CcSEcCtD
Clofazimine—Hyperglycaemia—Galantamine—Alzheimer's disease	0.00379	0.00923	CcSEcCtD
Clofazimine—Gastrointestinal haemorrhage—Donepezil—Alzheimer's disease	0.00377	0.00917	CcSEcCtD
Clofazimine—Depression—Galantamine—Alzheimer's disease	0.00374	0.0091	CcSEcCtD
Clofazimine—Abdominal pain upper—Donepezil—Alzheimer's disease	0.00345	0.00838	CcSEcCtD
Clofazimine—Hypokalaemia—Donepezil—Alzheimer's disease	0.00343	0.00835	CcSEcCtD
Clofazimine—Gastrointestinal haemorrhage—Memantine—Alzheimer's disease	0.00343	0.00833	CcSEcCtD
Clofazimine—Hepatitis—Galantamine—Alzheimer's disease	0.00337	0.00819	CcSEcCtD
Clofazimine—Gastrointestinal haemorrhage—Rivastigmine—Alzheimer's disease	0.00335	0.00815	CcSEcCtD
Clofazimine—Visual impairment—Galantamine—Alzheimer's disease	0.00324	0.00789	CcSEcCtD
Clofazimine—Eosinophilia—Donepezil—Alzheimer's disease	0.00323	0.00785	CcSEcCtD
Clofazimine—Hypokalaemia—Memantine—Alzheimer's disease	0.00312	0.00758	CcSEcCtD
Clofazimine—Abdominal pain upper—Rivastigmine—Alzheimer's disease	0.00306	0.00744	CcSEcCtD
Clofazimine—Hypokalaemia—Rivastigmine—Alzheimer's disease	0.00305	0.00742	CcSEcCtD
Clofazimine—Weight decreased—Donepezil—Alzheimer's disease	0.00295	0.00717	CcSEcCtD
Clofazimine—Hyperglycaemia—Donepezil—Alzheimer's disease	0.00294	0.00715	CcSEcCtD
Clofazimine—Depression—Donepezil—Alzheimer's disease	0.0029	0.00705	CcSEcCtD
Clofazimine—Jaundice—Donepezil—Alzheimer's disease	0.00283	0.00689	CcSEcCtD
Clofazimine—Anaemia—Galantamine—Alzheimer's disease	0.00271	0.00659	CcSEcCtD
Clofazimine—Weight decreased—Memantine—Alzheimer's disease	0.00268	0.00651	CcSEcCtD
Clofazimine—Hyperglycaemia—Memantine—Alzheimer's disease	0.00267	0.00649	CcSEcCtD
Clofazimine—Photosensitivity reaction—Rivastigmine—Alzheimer's disease	0.00264	0.00643	CcSEcCtD
Clofazimine—Depression—Memantine—Alzheimer's disease	0.00263	0.0064	CcSEcCtD
Clofazimine—Weight decreased—Rivastigmine—Alzheimer's disease	0.00262	0.00637	CcSEcCtD
Clofazimine—Hyperglycaemia—Rivastigmine—Alzheimer's disease	0.00261	0.00635	CcSEcCtD
Clofazimine—Hepatitis—Donepezil—Alzheimer's disease	0.00261	0.00635	CcSEcCtD
Clofazimine—Drowsiness—Rivastigmine—Alzheimer's disease	0.00258	0.00628	CcSEcCtD
Clofazimine—Depression—Rivastigmine—Alzheimer's disease	0.00257	0.00626	CcSEcCtD
Clofazimine—Visual impairment—Donepezil—Alzheimer's disease	0.00251	0.00612	CcSEcCtD
Clofazimine—Hepatitis—Memantine—Alzheimer's disease	0.00237	0.00576	CcSEcCtD
Clofazimine—Hepatitis—Rivastigmine—Alzheimer's disease	0.00232	0.00564	CcSEcCtD
Clofazimine—Visual impairment—Memantine—Alzheimer's disease	0.00228	0.00555	CcSEcCtD
Clofazimine—Anorexia—Galantamine—Alzheimer's disease	0.00228	0.00555	CcSEcCtD
Clofazimine—Visual impairment—Rivastigmine—Alzheimer's disease	0.00223	0.00543	CcSEcCtD
Clofazimine—Somnolence—Galantamine—Alzheimer's disease	0.00213	0.00517	CcSEcCtD
Clofazimine—Anaemia—Donepezil—Alzheimer's disease	0.0021	0.00511	CcSEcCtD
Clofazimine—Decreased appetite—Galantamine—Alzheimer's disease	0.00208	0.00506	CcSEcCtD
Clofazimine—Fatigue—Galantamine—Alzheimer's disease	0.00206	0.00502	CcSEcCtD
Clofazimine—Constipation—Galantamine—Alzheimer's disease	0.00205	0.00498	CcSEcCtD
Clofazimine—Anaemia—Memantine—Alzheimer's disease	0.00191	0.00464	CcSEcCtD
Clofazimine—Body temperature increased—Galantamine—Alzheimer's disease	0.00189	0.0046	CcSEcCtD
Clofazimine—Anaemia—Rivastigmine—Alzheimer's disease	0.00186	0.00454	CcSEcCtD
Clofazimine—Oedema—Donepezil—Alzheimer's disease	0.00185	0.00451	CcSEcCtD
Clofazimine—Anorexia—Donepezil—Alzheimer's disease	0.00177	0.0043	CcSEcCtD
Clofazimine—Asthenia—Galantamine—Alzheimer's disease	0.00172	0.00417	CcSEcCtD
Clofazimine—Oedema—Memantine—Alzheimer's disease	0.00168	0.00409	CcSEcCtD
Clofazimine—Somnolence—Donepezil—Alzheimer's disease	0.00165	0.00401	CcSEcCtD
Clofazimine—Oedema—Rivastigmine—Alzheimer's disease	0.00165	0.00401	CcSEcCtD
Clofazimine—Diarrhoea—Galantamine—Alzheimer's disease	0.00164	0.00398	CcSEcCtD
Clofazimine—Decreased appetite—Donepezil—Alzheimer's disease	0.00161	0.00392	CcSEcCtD
Clofazimine—Anorexia—Memantine—Alzheimer's disease	0.0016	0.0039	CcSEcCtD
Clofazimine—Fatigue—Donepezil—Alzheimer's disease	0.0016	0.00389	CcSEcCtD
Clofazimine—Constipation—Donepezil—Alzheimer's disease	0.00159	0.00386	CcSEcCtD
Clofazimine—Dizziness—Galantamine—Alzheimer's disease	0.00158	0.00385	CcSEcCtD
Clofazimine—Anorexia—Rivastigmine—Alzheimer's disease	0.00157	0.00382	CcSEcCtD
Clofazimine—Vomiting—Galantamine—Alzheimer's disease	0.00152	0.0037	CcSEcCtD
Clofazimine—Rash—Galantamine—Alzheimer's disease	0.00151	0.00367	CcSEcCtD
Clofazimine—Dermatitis—Galantamine—Alzheimer's disease	0.00151	0.00367	CcSEcCtD
Clofazimine—Headache—Galantamine—Alzheimer's disease	0.0015	0.00364	CcSEcCtD
Clofazimine—Somnolence—Memantine—Alzheimer's disease	0.0015	0.00364	CcSEcCtD
Clofazimine—Body temperature increased—Donepezil—Alzheimer's disease	0.00147	0.00356	CcSEcCtD
Clofazimine—Somnolence—Rivastigmine—Alzheimer's disease	0.00146	0.00356	CcSEcCtD
Clofazimine—Decreased appetite—Memantine—Alzheimer's disease	0.00146	0.00356	CcSEcCtD
Clofazimine—Fatigue—Memantine—Alzheimer's disease	0.00145	0.00353	CcSEcCtD
Clofazimine—Constipation—Memantine—Alzheimer's disease	0.00144	0.0035	CcSEcCtD
Clofazimine—Decreased appetite—Rivastigmine—Alzheimer's disease	0.00143	0.00348	CcSEcCtD
Clofazimine—Nausea—Galantamine—Alzheimer's disease	0.00142	0.00346	CcSEcCtD
Clofazimine—Fatigue—Rivastigmine—Alzheimer's disease	0.00142	0.00345	CcSEcCtD
Clofazimine—Constipation—Rivastigmine—Alzheimer's disease	0.00141	0.00343	CcSEcCtD
Clofazimine—Body temperature increased—Memantine—Alzheimer's disease	0.00133	0.00324	CcSEcCtD
Clofazimine—Asthenia—Donepezil—Alzheimer's disease	0.00133	0.00324	CcSEcCtD
Clofazimine—Pruritus—Donepezil—Alzheimer's disease	0.00131	0.00319	CcSEcCtD
Clofazimine—Body temperature increased—Rivastigmine—Alzheimer's disease	0.0013	0.00317	CcSEcCtD
Clofazimine—Diarrhoea—Donepezil—Alzheimer's disease	0.00127	0.00309	CcSEcCtD
Clofazimine—Dizziness—Donepezil—Alzheimer's disease	0.00123	0.00298	CcSEcCtD
Clofazimine—Asthenia—Memantine—Alzheimer's disease	0.00121	0.00294	CcSEcCtD
Clofazimine—Pruritus—Memantine—Alzheimer's disease	0.00119	0.0029	CcSEcCtD
Clofazimine—Asthenia—Rivastigmine—Alzheimer's disease	0.00118	0.00287	CcSEcCtD
Clofazimine—Vomiting—Donepezil—Alzheimer's disease	0.00118	0.00287	CcSEcCtD
Clofazimine—Rash—Donepezil—Alzheimer's disease	0.00117	0.00284	CcSEcCtD
Clofazimine—Dermatitis—Donepezil—Alzheimer's disease	0.00117	0.00284	CcSEcCtD
Clofazimine—Pruritus—Rivastigmine—Alzheimer's disease	0.00117	0.00283	CcSEcCtD
Clofazimine—Headache—Donepezil—Alzheimer's disease	0.00116	0.00282	CcSEcCtD
Clofazimine—Diarrhoea—Memantine—Alzheimer's disease	0.00115	0.0028	CcSEcCtD
Clofazimine—Diarrhoea—Rivastigmine—Alzheimer's disease	0.00113	0.00274	CcSEcCtD
Clofazimine—Dizziness—Memantine—Alzheimer's disease	0.00111	0.00271	CcSEcCtD
Clofazimine—Nausea—Donepezil—Alzheimer's disease	0.0011	0.00268	CcSEcCtD
Clofazimine—Dizziness—Rivastigmine—Alzheimer's disease	0.00109	0.00265	CcSEcCtD
Clofazimine—Vomiting—Memantine—Alzheimer's disease	0.00107	0.0026	CcSEcCtD
Clofazimine—Rash—Memantine—Alzheimer's disease	0.00106	0.00258	CcSEcCtD
Clofazimine—Dermatitis—Memantine—Alzheimer's disease	0.00106	0.00258	CcSEcCtD
Clofazimine—Headache—Memantine—Alzheimer's disease	0.00105	0.00256	CcSEcCtD
Clofazimine—Vomiting—Rivastigmine—Alzheimer's disease	0.00105	0.00255	CcSEcCtD
Clofazimine—Rash—Rivastigmine—Alzheimer's disease	0.00104	0.00253	CcSEcCtD
Clofazimine—Dermatitis—Rivastigmine—Alzheimer's disease	0.00104	0.00252	CcSEcCtD
Clofazimine—Headache—Rivastigmine—Alzheimer's disease	0.00103	0.00251	CcSEcCtD
Clofazimine—Nausea—Memantine—Alzheimer's disease	0.001	0.00243	CcSEcCtD
Clofazimine—Nausea—Rivastigmine—Alzheimer's disease	0.000978	0.00238	CcSEcCtD
Clofazimine—ABCB11—Synthesis of bile acids and bile salts—CYP46A1—Alzheimer's disease	1.2e-05	0.0993	CbGpPWpGaD
Clofazimine—ABCB11—Bile acid and bile salt metabolism—CYP46A1—Alzheimer's disease	9.54e-06	0.0789	CbGpPWpGaD
Clofazimine—ABCB1—ABC-family proteins mediated transport—ABCA7—Alzheimer's disease	5.73e-06	0.0474	CbGpPWpGaD
Clofazimine—ABCB11—Farnesoid X Receptor  Pathway—PPARGC1A—Alzheimer's disease	5.27e-06	0.0436	CbGpPWpGaD
Clofazimine—ABCB1—Codeine and Morphine Metabolism—CYP2D6—Alzheimer's disease	5.04e-06	0.0416	CbGpPWpGaD
Clofazimine—ABCB11—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCA1—Alzheimer's disease	3.84e-06	0.0317	CbGpPWpGaD
Clofazimine—ABCB1—Constitutive Androstane Receptor Pathway—PPP2R4—Alzheimer's disease	3.62e-06	0.0299	CbGpPWpGaD
Clofazimine—CYP3A4—Codeine and Morphine Metabolism—CYP2D6—Alzheimer's disease	3.1e-06	0.0257	CbGpPWpGaD
Clofazimine—CYP3A4—Tryptophan metabolism—DHCR24—Alzheimer's disease	2.59e-06	0.0214	CbGpPWpGaD
Clofazimine—CYP3A4—Constitutive Androstane Receptor Pathway—PPP2R4—Alzheimer's disease	2.23e-06	0.0184	CbGpPWpGaD
Clofazimine—ABCB11—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—Alzheimer's disease	2.2e-06	0.0182	CbGpPWpGaD
Clofazimine—CYP3A4—Irinotecan Pathway—BCHE—Alzheimer's disease	1.88e-06	0.0155	CbGpPWpGaD
Clofazimine—CYP3A4—Tryptophan metabolism—HSD17B10—Alzheimer's disease	1.79e-06	0.0148	CbGpPWpGaD
Clofazimine—CYP3A4—Fatty Acid Omega Oxidation—CYP2D6—Alzheimer's disease	1.78e-06	0.0147	CbGpPWpGaD
Clofazimine—ABCB11—Metabolism of lipids and lipoproteins—DHCR24—Alzheimer's disease	1.57e-06	0.013	CbGpPWpGaD
Clofazimine—ABCB1—Allograft Rejection—LRRK2—Alzheimer's disease	1.57e-06	0.0129	CbGpPWpGaD
Clofazimine—CYP3A4—Xenobiotics—CYP2D6—Alzheimer's disease	1.49e-06	0.0123	CbGpPWpGaD
Clofazimine—CYP3A4—Tamoxifen metabolism—CYP2D6—Alzheimer's disease	1.43e-06	0.0119	CbGpPWpGaD
Clofazimine—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP46A1—Alzheimer's disease	1.4e-06	0.0115	CbGpPWpGaD
Clofazimine—CYP3A4—Oxidation by Cytochrome P450—CYP46A1—Alzheimer's disease	1.38e-06	0.0114	CbGpPWpGaD
Clofazimine—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCA1—Alzheimer's disease	1.37e-06	0.0113	CbGpPWpGaD
Clofazimine—ABCB1—Constitutive Androstane Receptor Pathway—PPARGC1A—Alzheimer's disease	1.24e-06	0.0103	CbGpPWpGaD
Clofazimine—ABCB1—HIF-1-alpha transcription factor network—CP—Alzheimer's disease	1.16e-06	0.00963	CbGpPWpGaD
Clofazimine—CYP3A4—Farnesoid X Receptor  Pathway—PPARGC1A—Alzheimer's disease	1.16e-06	0.0096	CbGpPWpGaD
Clofazimine—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—GAB2—Alzheimer's disease	1.15e-06	0.0095	CbGpPWpGaD
Clofazimine—ABCB11—Metabolism of lipids and lipoproteins—PLD3—Alzheimer's disease	1.14e-06	0.00939	CbGpPWpGaD
Clofazimine—CYP3A4—Phase 1 - Functionalization of compounds—CYP46A1—Alzheimer's disease	1.13e-06	0.00936	CbGpPWpGaD
Clofazimine—ABCB11—Metabolism of lipids and lipoproteins—CYP46A1—Alzheimer's disease	1.05e-06	0.00867	CbGpPWpGaD
Clofazimine—CYP3A4—Tryptophan metabolism—MAOB—Alzheimer's disease	1.03e-06	0.00852	CbGpPWpGaD
Clofazimine—ABCB1—HIF-1-alpha transcription factor network—TF—Alzheimer's disease	9.9e-07	0.00819	CbGpPWpGaD
Clofazimine—ABCB1—HIF-1-alpha transcription factor network—ENO1—Alzheimer's disease	9.5e-07	0.00785	CbGpPWpGaD
Clofazimine—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCA1—Alzheimer's disease	8.46e-07	0.00699	CbGpPWpGaD
Clofazimine—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—Alzheimer's disease	7.86e-07	0.0065	CbGpPWpGaD
Clofazimine—CYP3A4—Constitutive Androstane Receptor Pathway—PPARGC1A—Alzheimer's disease	7.65e-07	0.00632	CbGpPWpGaD
Clofazimine—ABCB11—Metabolism—DHCR24—Alzheimer's disease	7e-07	0.00579	CbGpPWpGaD
Clofazimine—ABCB1—HIF-1-alpha transcription factor network—HMOX1—Alzheimer's disease	6.93e-07	0.00573	CbGpPWpGaD
Clofazimine—CYP3A4—Phase 1 - Functionalization of compounds—MAOB—Alzheimer's disease	6.75e-07	0.00558	CbGpPWpGaD
Clofazimine—ABCB11—Metabolism of lipids and lipoproteins—CHAT—Alzheimer's disease	6.53e-07	0.00539	CbGpPWpGaD
Clofazimine—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2D6—Alzheimer's disease	6.19e-07	0.00512	CbGpPWpGaD
Clofazimine—CYP3A4—Oxidation by Cytochrome P450—CYP2D6—Alzheimer's disease	6.11e-07	0.00505	CbGpPWpGaD
Clofazimine—CYP3A4—Biological oxidations—CYP46A1—Alzheimer's disease	6.01e-07	0.00497	CbGpPWpGaD
Clofazimine—ABCB1—Transmembrane transport of small molecules—ABCA7—Alzheimer's disease	5.99e-07	0.00495	CbGpPWpGaD
Clofazimine—ABCB11—Metabolism—CA4—Alzheimer's disease	5.95e-07	0.00492	CbGpPWpGaD
Clofazimine—CYP3A4—Metapathway biotransformation—CYP46A1—Alzheimer's disease	5.93e-07	0.0049	CbGpPWpGaD
Clofazimine—ABCB11—Metabolism of lipids and lipoproteins—A2M—Alzheimer's disease	5.82e-07	0.00481	CbGpPWpGaD
Clofazimine—ABCB1—Allograft Rejection—IL1A—Alzheimer's disease	5.62e-07	0.00465	CbGpPWpGaD
Clofazimine—ABCB11—Metabolism—GAPDHS—Alzheimer's disease	5.6e-07	0.00463	CbGpPWpGaD
Clofazimine—ABCB1—Transmembrane transport of small molecules—SLC24A4—Alzheimer's disease	5.34e-07	0.00441	CbGpPWpGaD
Clofazimine—ABCB1—HIF-1-alpha transcription factor network—LEP—Alzheimer's disease	5.31e-07	0.00439	CbGpPWpGaD
Clofazimine—ABCB11—Metabolism—ATP5A1—Alzheimer's disease	5.3e-07	0.00438	CbGpPWpGaD
Clofazimine—ABCB1—Integrated Pancreatic Cancer Pathway—EIF2AK2—Alzheimer's disease	5.25e-07	0.00434	CbGpPWpGaD
Clofazimine—CYP3A4—Phase 1 - Functionalization of compounds—PTGS1—Alzheimer's disease	5.12e-07	0.00423	CbGpPWpGaD
Clofazimine—ABCB11—Metabolism—PLD3—Alzheimer's disease	5.06e-07	0.00418	CbGpPWpGaD
Clofazimine—ABCB11—Metabolism of lipids and lipoproteins—ACHE—Alzheimer's disease	5.06e-07	0.00418	CbGpPWpGaD
Clofazimine—CYP3A4—Phase 1 - Functionalization of compounds—CYP2D6—Alzheimer's disease	5.02e-07	0.00415	CbGpPWpGaD
Clofazimine—ABCB11—Metabolism of lipids and lipoproteins—INPP5D—Alzheimer's disease	5e-07	0.00413	CbGpPWpGaD
Clofazimine—ABCB1—HIF-1-alpha transcription factor network—NOS2—Alzheimer's disease	4.95e-07	0.00409	CbGpPWpGaD
Clofazimine—ABCB1—Integrated Pancreatic Cancer Pathway—MAPT—Alzheimer's disease	4.86e-07	0.00402	CbGpPWpGaD
Clofazimine—ABCB11—Metabolism—HSD17B10—Alzheimer's disease	4.85e-07	0.00401	CbGpPWpGaD
Clofazimine—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—Alzheimer's disease	4.84e-07	0.004	CbGpPWpGaD
Clofazimine—ABCB11—Metabolism of lipids and lipoproteins—PTGS1—Alzheimer's disease	4.74e-07	0.00392	CbGpPWpGaD
Clofazimine—ABCB1—Integrated Pancreatic Cancer Pathway—CST3—Alzheimer's disease	4.71e-07	0.0039	CbGpPWpGaD
Clofazimine—ABCB11—Metabolism—CYP46A1—Alzheimer's disease	4.67e-07	0.00386	CbGpPWpGaD
Clofazimine—ABCB1—HIF-1-alpha transcription factor network—CREB1—Alzheimer's disease	4.56e-07	0.00377	CbGpPWpGaD
Clofazimine—ABCB11—Metabolism—ND1—Alzheimer's disease	4.51e-07	0.00373	CbGpPWpGaD
Clofazimine—ABCB1—Integrated Pancreatic Cancer Pathway—IAPP—Alzheimer's disease	4.41e-07	0.00364	CbGpPWpGaD
Clofazimine—ABCB11—Metabolism of lipids and lipoproteins—BCHE—Alzheimer's disease	4.41e-07	0.00364	CbGpPWpGaD
Clofazimine—ABCB1—Integrated Pancreatic Cancer Pathway—ACHE—Alzheimer's disease	4.33e-07	0.00358	CbGpPWpGaD
Clofazimine—ABCB11—Metabolism of lipids and lipoproteins—ABCA1—Alzheimer's disease	4.03e-07	0.00333	CbGpPWpGaD
Clofazimine—ABCB1—Integrated Pancreatic Cancer Pathway—GSK3A—Alzheimer's disease	3.84e-07	0.00317	CbGpPWpGaD
Clofazimine—ABCB1—Integrated Pancreatic Cancer Pathway—APP—Alzheimer's disease	3.77e-07	0.00312	CbGpPWpGaD
Clofazimine—ABCB1—Transmembrane transport of small molecules—SLC30A6—Alzheimer's disease	3.7e-07	0.00306	CbGpPWpGaD
Clofazimine—CYP3A4—Biological oxidations—MAOB—Alzheimer's disease	3.59e-07	0.00297	CbGpPWpGaD
Clofazimine—ABCB11—Metabolism of lipids and lipoproteins—PPARGC1A—Alzheimer's disease	3.47e-07	0.00287	CbGpPWpGaD
Clofazimine—ABCB11—Metabolism of lipids and lipoproteins—LPL—Alzheimer's disease	3.16e-07	0.00262	CbGpPWpGaD
Clofazimine—ABCB1—Transmembrane transport of small molecules—APOD—Alzheimer's disease	3.15e-07	0.0026	CbGpPWpGaD
Clofazimine—ABCB1—Allograft Rejection—IL1B—Alzheimer's disease	2.93e-07	0.00242	CbGpPWpGaD
Clofazimine—ABCB1—Allograft Rejection—CASP3—Alzheimer's disease	2.93e-07	0.00242	CbGpPWpGaD
Clofazimine—ABCB11—Metabolism—CHAT—Alzheimer's disease	2.91e-07	0.0024	CbGpPWpGaD
Clofazimine—ABCB11—Metabolism—TPI1—Alzheimer's disease	2.91e-07	0.0024	CbGpPWpGaD
Clofazimine—ABCB1—Integrated Pancreatic Cancer Pathway—BDNF—Alzheimer's disease	2.89e-07	0.00239	CbGpPWpGaD
Clofazimine—ABCB1—HIF-1-alpha transcription factor network—VEGFA—Alzheimer's disease	2.87e-07	0.00237	CbGpPWpGaD
Clofazimine—ABCB11—Metabolism—MAOB—Alzheimer's disease	2.79e-07	0.0023	CbGpPWpGaD
Clofazimine—CYP3A4—Biological oxidations—PTGS1—Alzheimer's disease	2.72e-07	0.00225	CbGpPWpGaD
Clofazimine—ABCB1—Integrated Pancreatic Cancer Pathway—BAX—Alzheimer's disease	2.69e-07	0.00222	CbGpPWpGaD
Clofazimine—ABCB11—Metabolism—GAPDH—Alzheimer's disease	2.68e-07	0.00222	CbGpPWpGaD
Clofazimine—CYP3A4—Biological oxidations—CYP2D6—Alzheimer's disease	2.67e-07	0.0022	CbGpPWpGaD
Clofazimine—ABCB11—Metabolism of lipids and lipoproteins—APOE—Alzheimer's disease	2.65e-07	0.00219	CbGpPWpGaD
Clofazimine—CYP3A4—Metapathway biotransformation—CYP2D6—Alzheimer's disease	2.63e-07	0.00217	CbGpPWpGaD
Clofazimine—ABCB11—Metabolism of lipids and lipoproteins—CAV1—Alzheimer's disease	2.63e-07	0.00217	CbGpPWpGaD
Clofazimine—ABCB11—Metabolism—A2M—Alzheimer's disease	2.59e-07	0.00214	CbGpPWpGaD
Clofazimine—ABCB1—Metabolism—DHCR24—Alzheimer's disease	2.5e-07	0.00207	CbGpPWpGaD
Clofazimine—ABCB1—Allograft Rejection—VEGFA—Alzheimer's disease	2.48e-07	0.00205	CbGpPWpGaD
Clofazimine—ABCB11—Metabolism of lipids and lipoproteins—PPARG—Alzheimer's disease	2.31e-07	0.00191	CbGpPWpGaD
Clofazimine—ABCB1—Allograft Rejection—TGFB1—Alzheimer's disease	2.28e-07	0.00188	CbGpPWpGaD
Clofazimine—ABCB11—Metabolism—ACHE—Alzheimer's disease	2.25e-07	0.00186	CbGpPWpGaD
Clofazimine—ABCB11—Metabolism—INPP5D—Alzheimer's disease	2.23e-07	0.00184	CbGpPWpGaD
Clofazimine—ABCB1—Integrated Pancreatic Cancer Pathway—ESR1—Alzheimer's disease	2.17e-07	0.00179	CbGpPWpGaD
Clofazimine—ABCB1—Allograft Rejection—TNF—Alzheimer's disease	2.13e-07	0.00176	CbGpPWpGaD
Clofazimine—ABCB1—Metabolism—CA4—Alzheimer's disease	2.13e-07	0.00176	CbGpPWpGaD
Clofazimine—ABCB11—Metabolism—ENO1—Alzheimer's disease	2.11e-07	0.00175	CbGpPWpGaD
Clofazimine—ABCB11—Metabolism—PTGS1—Alzheimer's disease	2.11e-07	0.00175	CbGpPWpGaD
Clofazimine—ABCB11—Metabolism—CYP2D6—Alzheimer's disease	2.07e-07	0.00171	CbGpPWpGaD
Clofazimine—ABCB1—Metabolism—GAPDHS—Alzheimer's disease	2e-07	0.00165	CbGpPWpGaD
Clofazimine—ABCB1—Transmembrane transport of small molecules—CP—Alzheimer's disease	1.98e-07	0.00163	CbGpPWpGaD
Clofazimine—ABCB11—Metabolism—BCHE—Alzheimer's disease	1.96e-07	0.00162	CbGpPWpGaD
Clofazimine—ABCB1—Integrated Pancreatic Cancer Pathway—CREB1—Alzheimer's disease	1.95e-07	0.00161	CbGpPWpGaD
Clofazimine—ABCB1—Metabolism—ATP5A1—Alzheimer's disease	1.9e-07	0.00157	CbGpPWpGaD
Clofazimine—ABCB1—Integrated Pancreatic Cancer Pathway—IGF1—Alzheimer's disease	1.88e-07	0.00155	CbGpPWpGaD
Clofazimine—ABCB11—Metabolism—PLCB1—Alzheimer's disease	1.85e-07	0.00153	CbGpPWpGaD
Clofazimine—ABCB1—HIF-1-alpha transcription factor network—AKT1—Alzheimer's disease	1.83e-07	0.00151	CbGpPWpGaD
Clofazimine—ABCB11—Metabolism of lipids and lipoproteins—PTGS2—Alzheimer's disease	1.82e-07	0.0015	CbGpPWpGaD
Clofazimine—ABCB1—Metabolism—PLD3—Alzheimer's disease	1.81e-07	0.00149	CbGpPWpGaD
Clofazimine—ABCB11—Metabolism—ABCA1—Alzheimer's disease	1.8e-07	0.00148	CbGpPWpGaD
Clofazimine—ABCB1—Metabolism—HSD17B10—Alzheimer's disease	1.73e-07	0.00143	CbGpPWpGaD
Clofazimine—ABCB1—Transmembrane transport of small molecules—TF—Alzheimer's disease	1.68e-07	0.00139	CbGpPWpGaD
Clofazimine—ABCB1—Metabolism—CYP46A1—Alzheimer's disease	1.67e-07	0.00138	CbGpPWpGaD
Clofazimine—ABCB1—Integrated Pancreatic Cancer Pathway—BCL2—Alzheimer's disease	1.64e-07	0.00135	CbGpPWpGaD
Clofazimine—ABCB1—Metabolism—ND1—Alzheimer's disease	1.61e-07	0.00133	CbGpPWpGaD
Clofazimine—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—Alzheimer's disease	1.56e-07	0.00129	CbGpPWpGaD
Clofazimine—ABCB11—Metabolism—PPARGC1A—Alzheimer's disease	1.55e-07	0.00128	CbGpPWpGaD
Clofazimine—CYP3A4—Metabolism—DHCR24—Alzheimer's disease	1.54e-07	0.00127	CbGpPWpGaD
Clofazimine—ABCB11—Metabolism—HMOX1—Alzheimer's disease	1.54e-07	0.00127	CbGpPWpGaD
Clofazimine—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—Alzheimer's disease	1.44e-07	0.00119	CbGpPWpGaD
Clofazimine—ABCB11—Metabolism—LPL—Alzheimer's disease	1.41e-07	0.00116	CbGpPWpGaD
Clofazimine—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK8—Alzheimer's disease	1.33e-07	0.0011	CbGpPWpGaD
Clofazimine—CYP3A4—Metabolism—CA4—Alzheimer's disease	1.31e-07	0.00108	CbGpPWpGaD
Clofazimine—ABCB11—Metabolism—MTHFR—Alzheimer's disease	1.27e-07	0.00105	CbGpPWpGaD
Clofazimine—CYP3A4—Metabolism—GAPDHS—Alzheimer's disease	1.23e-07	0.00102	CbGpPWpGaD
Clofazimine—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—Alzheimer's disease	1.22e-07	0.00101	CbGpPWpGaD
Clofazimine—ABCB11—Metabolism—CALM1—Alzheimer's disease	1.19e-07	0.00098	CbGpPWpGaD
Clofazimine—ABCB11—Metabolism—APOE—Alzheimer's disease	1.18e-07	0.000976	CbGpPWpGaD
Clofazimine—ABCB1—Transmembrane transport of small molecules—HMOX1—Alzheimer's disease	1.18e-07	0.000972	CbGpPWpGaD
Clofazimine—ABCB11—Metabolism—CAV1—Alzheimer's disease	1.17e-07	0.000967	CbGpPWpGaD
Clofazimine—CYP3A4—Metabolism—ATP5A1—Alzheimer's disease	1.17e-07	0.000965	CbGpPWpGaD
Clofazimine—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—Alzheimer's disease	1.12e-07	0.000929	CbGpPWpGaD
Clofazimine—CYP3A4—Metabolism—PLD3—Alzheimer's disease	1.11e-07	0.000921	CbGpPWpGaD
Clofazimine—CYP3A4—Metabolism—HSD17B10—Alzheimer's disease	1.07e-07	0.000883	CbGpPWpGaD
Clofazimine—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—Alzheimer's disease	1.05e-07	0.000868	CbGpPWpGaD
Clofazimine—ABCB1—Metabolism—TPI1—Alzheimer's disease	1.04e-07	0.000859	CbGpPWpGaD
Clofazimine—ABCB1—Metabolism—CHAT—Alzheimer's disease	1.04e-07	0.000859	CbGpPWpGaD
Clofazimine—ABCB11—Metabolism—PPARG—Alzheimer's disease	1.03e-07	0.00085	CbGpPWpGaD
Clofazimine—CYP3A4—Metabolism—CYP46A1—Alzheimer's disease	1.03e-07	0.00085	CbGpPWpGaD
Clofazimine—ABCB11—Metabolism—INS—Alzheimer's disease	1.01e-07	0.000834	CbGpPWpGaD
Clofazimine—ABCB1—Metabolism—MAOB—Alzheimer's disease	9.96e-08	0.000823	CbGpPWpGaD
Clofazimine—CYP3A4—Metabolism—ND1—Alzheimer's disease	9.93e-08	0.000821	CbGpPWpGaD
Clofazimine—ABCB1—Metabolism—GAPDH—Alzheimer's disease	9.59e-08	0.000792	CbGpPWpGaD
Clofazimine—ABCB1—Metabolism—A2M—Alzheimer's disease	9.26e-08	0.000765	CbGpPWpGaD
Clofazimine—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—Alzheimer's disease	9.26e-08	0.000765	CbGpPWpGaD
Clofazimine—ABCB11—Metabolism—NOS3—Alzheimer's disease	8.85e-08	0.000731	CbGpPWpGaD
Clofazimine—ABCB11—Metabolism—PTGS2—Alzheimer's disease	8.09e-08	0.000669	CbGpPWpGaD
Clofazimine—ABCB1—Metabolism—ACHE—Alzheimer's disease	8.05e-08	0.000666	CbGpPWpGaD
Clofazimine—ABCB1—Metabolism—INPP5D—Alzheimer's disease	7.96e-08	0.000658	CbGpPWpGaD
Clofazimine—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—Alzheimer's disease	7.82e-08	0.000646	CbGpPWpGaD
Clofazimine—ABCB1—Metabolism—ENO1—Alzheimer's disease	7.55e-08	0.000624	CbGpPWpGaD
Clofazimine—ABCB1—Metabolism—PTGS1—Alzheimer's disease	7.55e-08	0.000624	CbGpPWpGaD
Clofazimine—ABCB1—Metabolism—CYP2D6—Alzheimer's disease	7.4e-08	0.000612	CbGpPWpGaD
Clofazimine—ABCB1—Metabolism—BCHE—Alzheimer's disease	7.02e-08	0.00058	CbGpPWpGaD
Clofazimine—ABCB1—Metabolism—PLCB1—Alzheimer's disease	6.62e-08	0.000547	CbGpPWpGaD
Clofazimine—ABCB1—Metabolism—ABCA1—Alzheimer's disease	6.42e-08	0.00053	CbGpPWpGaD
Clofazimine—CYP3A4—Metabolism—TPI1—Alzheimer's disease	6.4e-08	0.000529	CbGpPWpGaD
Clofazimine—CYP3A4—Metabolism—CHAT—Alzheimer's disease	6.4e-08	0.000529	CbGpPWpGaD
Clofazimine—CYP3A4—Metabolism—MAOB—Alzheimer's disease	6.14e-08	0.000507	CbGpPWpGaD
Clofazimine—CYP3A4—Metabolism—GAPDH—Alzheimer's disease	5.91e-08	0.000488	CbGpPWpGaD
Clofazimine—CYP3A4—Metabolism—A2M—Alzheimer's disease	5.7e-08	0.000471	CbGpPWpGaD
Clofazimine—ABCB1—Metabolism—PPARGC1A—Alzheimer's disease	5.53e-08	0.000457	CbGpPWpGaD
Clofazimine—ABCB1—Metabolism—HMOX1—Alzheimer's disease	5.51e-08	0.000455	CbGpPWpGaD
Clofazimine—ABCB1—Metabolism—LPL—Alzheimer's disease	5.04e-08	0.000416	CbGpPWpGaD
Clofazimine—CYP3A4—Metabolism—ACHE—Alzheimer's disease	4.96e-08	0.00041	CbGpPWpGaD
Clofazimine—CYP3A4—Metabolism—INPP5D—Alzheimer's disease	4.9e-08	0.000405	CbGpPWpGaD
Clofazimine—CYP3A4—Metabolism—PTGS1—Alzheimer's disease	4.65e-08	0.000384	CbGpPWpGaD
Clofazimine—CYP3A4—Metabolism—ENO1—Alzheimer's disease	4.65e-08	0.000384	CbGpPWpGaD
Clofazimine—CYP3A4—Metabolism—CYP2D6—Alzheimer's disease	4.56e-08	0.000377	CbGpPWpGaD
Clofazimine—ABCB1—Metabolism—MTHFR—Alzheimer's disease	4.53e-08	0.000375	CbGpPWpGaD
Clofazimine—CYP3A4—Metabolism—BCHE—Alzheimer's disease	4.32e-08	0.000357	CbGpPWpGaD
Clofazimine—ABCB1—Metabolism—CALM1—Alzheimer's disease	4.24e-08	0.00035	CbGpPWpGaD
Clofazimine—ABCB1—Metabolism—APOE—Alzheimer's disease	4.22e-08	0.000349	CbGpPWpGaD
Clofazimine—ABCB1—Metabolism—CAV1—Alzheimer's disease	4.18e-08	0.000346	CbGpPWpGaD
Clofazimine—CYP3A4—Metabolism—PLCB1—Alzheimer's disease	4.08e-08	0.000337	CbGpPWpGaD
Clofazimine—ABCB11—Metabolism—AKT1—Alzheimer's disease	4.07e-08	0.000336	CbGpPWpGaD
Clofazimine—CYP3A4—Metabolism—ABCA1—Alzheimer's disease	3.95e-08	0.000327	CbGpPWpGaD
Clofazimine—ABCB1—Metabolism—PPARG—Alzheimer's disease	3.68e-08	0.000304	CbGpPWpGaD
Clofazimine—ABCB1—Metabolism—INS—Alzheimer's disease	3.61e-08	0.000298	CbGpPWpGaD
Clofazimine—CYP3A4—Metabolism—PPARGC1A—Alzheimer's disease	3.41e-08	0.000282	CbGpPWpGaD
Clofazimine—CYP3A4—Metabolism—HMOX1—Alzheimer's disease	3.39e-08	0.00028	CbGpPWpGaD
Clofazimine—ABCB1—Metabolism—NOS3—Alzheimer's disease	3.16e-08	0.000261	CbGpPWpGaD
Clofazimine—CYP3A4—Metabolism—LPL—Alzheimer's disease	3.1e-08	0.000256	CbGpPWpGaD
Clofazimine—ABCB1—Metabolism—PTGS2—Alzheimer's disease	2.89e-08	0.000239	CbGpPWpGaD
Clofazimine—CYP3A4—Metabolism—MTHFR—Alzheimer's disease	2.79e-08	0.000231	CbGpPWpGaD
Clofazimine—CYP3A4—Metabolism—CALM1—Alzheimer's disease	2.61e-08	0.000216	CbGpPWpGaD
Clofazimine—CYP3A4—Metabolism—APOE—Alzheimer's disease	2.6e-08	0.000215	CbGpPWpGaD
Clofazimine—CYP3A4—Metabolism—CAV1—Alzheimer's disease	2.58e-08	0.000213	CbGpPWpGaD
Clofazimine—CYP3A4—Metabolism—PPARG—Alzheimer's disease	2.26e-08	0.000187	CbGpPWpGaD
Clofazimine—CYP3A4—Metabolism—INS—Alzheimer's disease	2.22e-08	0.000184	CbGpPWpGaD
Clofazimine—CYP3A4—Metabolism—NOS3—Alzheimer's disease	1.95e-08	0.000161	CbGpPWpGaD
Clofazimine—CYP3A4—Metabolism—PTGS2—Alzheimer's disease	1.78e-08	0.000147	CbGpPWpGaD
Clofazimine—ABCB1—Metabolism—AKT1—Alzheimer's disease	1.45e-08	0.00012	CbGpPWpGaD
Clofazimine—CYP3A4—Metabolism—AKT1—Alzheimer's disease	8.96e-09	7.4e-05	CbGpPWpGaD
